Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UKNOWN
UNII: 1N3L70MDFX

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Receptor tyrosine-protein kinase erbB-3 inhibitor Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 2 D001943 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3545071
FDA SRS 1N3L70MDFX